首页> 美国卫生研究院文献>ERJ Open Research >Physicians perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection
【2h】

Physicians perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection

机译:医师对治疗潜伏性结核感染的临床交流中的沟通和决策的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the study was to explore the views of tuberculosis (TB) physicians on treatment of latent TB infection (LTBI), focusing on decision making and communication in clinical practice.20 Australian TB physicians participated in a semistructured interview in person or over the telephone. Interviews were recorded, transcribed and analysed thematically.The study identified challenges that physicians face when discussing treatment for LTBI with patients. These included difficulties explaining the concept of latency (in particular to patients from culturally and linguistically diverse backgrounds) and providing guidance to patients while still framing treatment decisions as a choice. Tailored estimates of the risk of developing TB and the risk of developing an adverse effect from LTBI treatment were considered the most important information for decision making and discussion with patients. Physicians acknowledged that there is a significant amount of unwarranted treatment variation, which they attributed to the lack of evidence about the risk–benefit balance of LTBI treatment in certain scenarios and guidelines that refer to the need for case-by-case decision making in many instances.In order to successfully implement LTBI treatment at a clinical level, consideration should be given to research on how to best address communication challenges arising in clinical encounters.
机译:这项研究的目的是探讨结核病(TB)医师对潜伏性结核感染(LTBI)的治疗观点,重点是临床实践中的决策和沟通。20澳大利亚结核病医师亲自或半身参加半结构式访谈电话。访谈记录,记录和主题分析进行了分析。研究确定了医师在与患者讨论LTBI治疗时面临的挑战。这些困难包括难以解释潜伏期的概念(特别是对于来自文化和语言背景不同的患者),以及在为患者制定治疗决策时提供指导。量身定制的结核病风险评估和LTBI治疗产生不良反应的风险评估被认为是决策和与患者讨论的最重要信息。医师承认存在大量不必要的治疗差异,原因是在某些情况下缺乏关于LTBI治疗的风险-收益平衡的证据,而在许多情况下,指南都需要逐案决策为了在临床上成功实施LTBI治疗,应考虑研究如何最有效地应对临床遭遇中出现的沟通挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号